NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,799 | +2.3% | 6,664 | +1.3% | 0.05% | +6.4% |
| Q2 2023 | $663,689 | +11.7% | 6,577 | +1.9% | 0.05% | +11.9% |
| Q1 2023 | $593,956 | -3.1% | 6,456 | -4.5% | 0.04% | -10.6% |
| Q4 2022 | $613,178 | +25.9% | 6,759 | +5.5% | 0.05% | +14.6% |
| Q3 2022 | $487,000 | -4.1% | 6,404 | +6.5% | 0.04% | 0.0% |
| Q2 2022 | $508,000 | -4.7% | 6,013 | -1.0% | 0.04% | +13.9% |
| Q1 2022 | $533,000 | -0.4% | 6,075 | -0.7% | 0.04% | +2.9% |
| Q4 2021 | $535,000 | +7.4% | 6,118 | +0.4% | 0.04% | -2.8% |
| Q3 2021 | $498,000 | -2.7% | 6,091 | +8.5% | 0.04% | -10.0% |
| Q2 2021 | $512,000 | +71.2% | 5,612 | +60.4% | 0.04% | +37.9% |
| Q1 2021 | $299,000 | -12.3% | 3,498 | -3.0% | 0.03% | -17.1% |
| Q4 2020 | $341,000 | -45.9% | 3,607 | -50.2% | 0.04% | -27.1% |
| Q3 2020 | $630,000 | +76.5% | 7,242 | +92.4% | 0.05% | +6.7% |
| Q4 2019 | $357,000 | – | 3,765 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |